 |
|
|
| |
DTG Versus LPV/r in Second Line (DAWNING):
Outcomes by WHO-Recommended NRTI Backbone
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston, MA
Michael Aboud,1Carlos Brites,2Hongzhou Lu,3Khuanchai Supparatpinyo,4Luis Hercilla,5Jörg Sievers,1Maria Claudia Nascimento,1Judy Hopking,6Mark Underwood,7Dannae Brown,8Martin Gartland,7Kimberly Smith7
1ViiV Healthcare, Brentford, UK; 2Federal University of Bahia, Salvador, Brazil; 3Fudan University, Shanghai, China; 4Chiang Mai University, Chiang Mai, Thailand; 5Hospital Nacional Alberto Sabogal Sologuren, Callao, Peru; 6GlaxoSmithKline, Uxbridge, UK; 7ViiV Healthcare, Research Triangle Park, NC, USA; 8ViiV Healthcare, Abbotsford, Australia
|
| |
|
|
|
|
|
